Identifying niche factors regulating distinct properties of AT2 stem cells

识别调节 AT2 干细胞独特特性的生态位因子

基本信息

  • 批准号:
    9576667
  • 负责人:
  • 金额:
    $ 56.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-22 至 2022-05-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY A number of serious respiratory diseases cause problems with gas exchange, which is the principal function of the lungs. Some of these are sudden in onset, like lung injury from a severe pneumonia, while others develop over long periods of time, like COPD and Idiopathic Pulmonary Fibrosis (IPF). There is some evidence that the chronic forms of respiratory failure result from loss of the capacity of the lungs to maintain themselves, in part due to dysfunction of resident lung stem cells that normally perform this role. Therefore, discovering the specific molecular and cellular mechanisms by which lung stem cells are regulated throughout life may be helpful for understanding how COPD and IPF develop. Achieving this deep level of understanding about lung stem cell regulation may lead to improved strategies to predict, diagnose, and even pharmacologically treat such diseases. Furthermore, given the easy accessibility of the lung via medical bronchoscopy, it is an ideal organ to target with the delivery of healthy stem cells that might prevent disease progression or even produce improvement if they can be successfully transplanted into diseased lungs. We have found that one of the functional cells in the gas exchange region, the alveolar type II (AT2) cell, acts as a stem cell for mouse lung throughout the lifespan, and identified several factors that regulate its activity. The AIMS of this proposal are to expand our understanding of how these stem cells are regulated by studying the local environment that provides the signals that control their activity, including proliferation and differentiation. We will investigate three specific and distinct aspects of the stem cell behavior, including how it is induced to proliferate to generate new cells, how it attains the capacity to transiently regulate itself in response to injury, and whether the regulatory environment is as or more important than the stem cell itself for maintaining the lungs over the lifespan. Our findings will significantly deepen our understanding of precisely how these lung stem cells can be deliberately manipulated to generate large numbers suitable for cell transplantation, or by pharmacologically driving their activity for therapeutic 're-growth' purposes.
项目摘要 许多严重的呼吸道疾病引起气体交换问题,而气体交换是呼吸系统的主要功能。 肺其中一些是突然发作的,如严重肺炎造成的肺损伤,而另一些则是发展中国家的疾病。 慢性阻塞性肺疾病(COPD)和特发性肺纤维化(IPF)。有证据表明, 慢性形式的呼吸衰竭部分是由于肺丧失了维持自身的能力, 这是由于通常发挥这一作用的常驻肺干细胞的功能障碍。因此,发现 在整个生命过程中调节肺干细胞的特定分子和细胞机制可能 有助于了解COPD和IPF的发展过程。对肺有了更深层次的了解 干细胞调控可能会导致预测、诊断甚至是治疗的策略得到改进 这样的疾病。此外,考虑到通过医学支气管镜检查容易接近肺部, 通过输送健康的干细胞来靶向器官,这些干细胞可能会阻止疾病进展,甚至产生 如果它们能够成功移植到患病的肺部,就会有所改善。我们发现, 在气体交换区域的功能细胞,肺泡II型(AT 2)细胞,作为小鼠肺的干细胞 并确定了几个调节其活性的因素。本提案的目标是 通过研究当地环境,扩大我们对这些干细胞是如何调节的理解, 提供控制其活性的信号,包括增殖和分化。我们将调查 干细胞行为的三个具体和不同的方面,包括它是如何被诱导增殖, 产生新的细胞,它如何获得对损伤做出反应的瞬时调节自身的能力,以及是否 调节环境与干细胞本身一样重要,甚至更重要,以维持肺超过 寿命我们的研究结果将大大加深我们对这些肺干细胞是如何被 故意操纵以产生大量适合于细胞移植的细胞,或通过细胞移植, 驱动它们的活性用于治疗性“再生长”目的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tushar Jasubhai DESAI其他文献

Tushar Jasubhai DESAI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tushar Jasubhai DESAI', 18)}}的其他基金

Cellular and molecular mechanisms of alveolar repair
肺泡修复的细胞和分子机制
  • 批准号:
    10750085
  • 财政年份:
    2023
  • 资助金额:
    $ 56.28万
  • 项目类别:
Next-Generation Genomic Imaging Technology
下一代基因组成像技术
  • 批准号:
    10460108
  • 财政年份:
    2018
  • 资助金额:
    $ 56.28万
  • 项目类别:
Identifying niche factors regulating distinct properties of AT2 stem cells
识别调节 AT2 干细胞独特特性的生态位因子
  • 批准号:
    9767857
  • 财政年份:
    2018
  • 资助金额:
    $ 56.28万
  • 项目类别:
Next-Generation Genomic Imaging Technology
下一代基因组成像技术
  • 批准号:
    10026446
  • 财政年份:
    2018
  • 资助金额:
    $ 56.28万
  • 项目类别:
Identifying niche factors regulating distinct properties of AT2 stem cells
识别调节 AT2 干细胞独特特性的生态位因子
  • 批准号:
    10178079
  • 财政年份:
    2018
  • 资助金额:
    $ 56.28万
  • 项目类别:
Single Cell Profiling and In Vivo Cellular Interrogation of Alveolar Stem Cells
肺泡干细胞的单细胞分析和体内细胞分析
  • 批准号:
    9130386
  • 财政年份:
    2015
  • 资助金额:
    $ 56.28万
  • 项目类别:
Development and maintenance of the alveolar type 1 cell
肺泡 1 型细胞的发育和维持
  • 批准号:
    7386391
  • 财政年份:
    2008
  • 资助金额:
    $ 56.28万
  • 项目类别:
Development and maintenance of the alveolar type 1 cell
肺泡 1 型细胞的发育和维持
  • 批准号:
    7552017
  • 财政年份:
    2008
  • 资助金额:
    $ 56.28万
  • 项目类别:
Development and maintenance of the alveolar type 1 cell
肺泡 1 型细胞的发育和维持
  • 批准号:
    7754452
  • 财政年份:
    2008
  • 资助金额:
    $ 56.28万
  • 项目类别:
Development and maintenance of the alveolar type 1 cell
肺泡 1 型细胞的发育和维持
  • 批准号:
    8207255
  • 财政年份:
    2008
  • 资助金额:
    $ 56.28万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 56.28万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了